POAI News and Press, Predictive Oncology Inc. From 04/19/24

2024-04-19 10:00:25 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among m...

2024-04-01 10:25:24 ET Predictive Oncology Inc. (POAI) Q4 2023 Earnings Conference Call April 01, 2024 08:30 A.M. ET Company Participants Glenn Garmont - IR Raymond F. Vennare - CEO and Chairman Josh Blacher - Interim CFO Conference Call Participants ...

2024-03-29 01:12:42 ET More on Predictive Oncology Financial information for Predictive Oncology Read the full article on Seeking Alpha For further details see: Predictive Oncology GAAP EPS of -$3.48, revenue of $1.78M

PITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility, to accelerate onc...

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...

Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...

PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive Officer, will participate in three upcoming investor conferences. Please see below for additiona...

2024-01-18 12:09:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artificial intelligence and penny stocks don’t necessarily go together like peanut butter and jelly, but there is some allure to AI penny stocks for risk-tolerant investors. In 2...

PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive Officer, will present at the upcoming Biotech Showcase, in San Francisco, CA, on January 9, 2024...

2023-11-14 13:27:15 ET Predictive Oncology Inc. (POAI) Q3 2023 Earnings Conference Call November 14, 2023, 08:30 AM ET Company Participants Glenn Garmont - IR Raymond Vennare - CEO and Chairman Josh Blacher - CFO Conference Call Participants Present...